Follow the GENELUX CORP share price and the full management transaction log of the company, a listed equity based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €116.6m. The latest transaction was filed on 4 August 2026 (Cession). Among the most active insiders: Yu Yong. All data is accessible without an account.
140
Insider Decl.
n/a
Thresholds
€1,144
10 ops.
Buy Volume
€8m
64 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate GENELUX CORP Strong Buy (bullish), based on 6 analysts. Average price target: US$17.50.
44Σ signal
Buys €1,144€8m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
GENELUX CORP es una empresa que cotiza en el NASDAQ, centrada en el desarrollo de terapias innovadoras para el tratamiento del cáncer. Se especializa en el uso de tecnología de virus oncolíticos para atacar y destruir células cancerosas.